Clinical Trials Sponsored by Catabasis Pharmaceuticals
Total 19808 results
-
Endo PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedDupuytren's DiseaseUnited States, Australia
-
Inovio PharmaceuticalsCompletedHead and Neck CancerUnited States
-
Ferring PharmaceuticalsCompletedSeptic ShockDenmark, United States, Belgium, Canada
-
Anthera PharmaceuticalsCompletedIgA NephropathyCzechia, Germany, Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, United Kingdom
-
Inovio PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompletedFemale InfertilityDenmark
-
Jazz PharmaceuticalsApproved for marketingSecondary AMLUnited States
-
Deltanoid PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
Sunesis PharmaceuticalsCompletedEpithelial Ovarian CancerUnited States, Canada
-
Regeneron PharmaceuticalsTerminated
-
Braeburn PharmaceuticalsCompletedSchizophreniaUnited States
-
Alexion PharmaceuticalsTerminatedAntiphospholipid (aPL)-PositiveUnited States, Italy, Brazil, France, Japan, United Kingdom
-
Ferring PharmaceuticalsCompletedNocturiaUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, France, Germany
-
Avanir PharmaceuticalsTerminatedPseudobulbar Affect (Involuntary Laughing and/or Crying)United States
-
Ferring PharmaceuticalsCompletedIn Vitro Fertilisation (IVF) TreatmentCzechia, Belgium, Spain
-
Ferring PharmaceuticalsCompletedOvarian Hyperstimulation Syndrome (OHSS)France
-
Rigel PharmaceuticalsCompletedRheumatoid ArthritisBelgium, United States, Colombia, France, Germany, Italy, Peru
-
Regeneron PharmaceuticalsCompletedIntercritical GoutUnited States, Canada
-
Regeneron PharmaceuticalsCompletedGoutGermany, Taiwan, India, South Africa, Indonesia
-
KAI PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
Avanir PharmaceuticalsCompleted
-
KAI PharmaceuticalsCompleted
-
Concert PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompletedSeptic ShockDenmark, Belgium
-
Prolong PharmaceuticalsCompleted
-
Merrimack PharmaceuticalsWithdrawn
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Regeneron PharmaceuticalsCompletedHealthy VolunteersUnited States
-
ASLAN PharmaceuticalsCompletedHealthy Elderly Subjects (Age ≥55 Years)Singapore
-
TetraLogic PharmaceuticalsUnknownAlopecia Areata
-
TetraLogic PharmaceuticalsUnknownCutaneous T-Cell Lymphoma (CTCL)United States
-
TetraLogic PharmaceuticalsTerminatedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States, Spain, Australia, Germany
-
Regeneron PharmaceuticalsCompletedHealthyUnited States
-
Rigel PharmaceuticalsCompletedChronic Graft-versus-host DiseaseUnited States
-
SciClone PharmaceuticalsUnknownEGFR Mutation Positive Non Small Cell Lung CancerItaly
-
SciClone PharmaceuticalsUnknown
-
Rigel PharmaceuticalsCompletedT Cell LymphomaUnited States, Canada
-
Tarix PharmaceuticalsCompletedMiscellaneous Peripheral Blood Cell AbnormalitiesUnited States
-
Tarix PharmaceuticalsWithdrawnHematologic MalignanciesUnited States
-
Tarix PharmaceuticalsWithdrawnHematologic MalignanciesUnited States
-
Jazz PharmaceuticalsWithdrawn
-
Jazz PharmaceuticalsTerminatedHead and Neck Squamous Cell CarcinomaUnited Kingdom
-
Merrimack PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, France
-
Peregrine PharmaceuticalsWithdrawn
-
Alnylam PharmaceuticalsCompletedFamilial Amyloidotic Cardiomyopathy (FAC)United States, France, Spain, United Kingdom, Belgium, Brazil
-
Avanir PharmaceuticalsCompletedPain | Diabetic NeuropathyUnited States
-
Rigel PharmaceuticalsCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, DiscoidUnited States, Canada
-
Avanir PharmaceuticalsCompletedStroke | Parkinson's Disease | Traumatic Brain Injury | Alzheimer's DiseaseUnited States